Cargando…

Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis

BACKGROUND: This study characterized vessel wall imaging (VWI) features of Moyamoya disease (MMD) in a predominantly adult population at a North American center. METHODS: Consecutive patients with VWI were included. Twelve arterial segments were analyzed for wall thickening, degree and pattern of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Anthony S., Klaas, James P., Johnson, Matthew P., Benson, John C., Shlapak, Darya, Lanzino, Giuseppe, Savastano, Luis E., Lehman, Vance T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673330/
https://www.ncbi.nlm.nih.gov/pubmed/36397005
http://dx.doi.org/10.1186/s12880-022-00930-2
_version_ 1784832921590300672
author Larson, Anthony S.
Klaas, James P.
Johnson, Matthew P.
Benson, John C.
Shlapak, Darya
Lanzino, Giuseppe
Savastano, Luis E.
Lehman, Vance T.
author_facet Larson, Anthony S.
Klaas, James P.
Johnson, Matthew P.
Benson, John C.
Shlapak, Darya
Lanzino, Giuseppe
Savastano, Luis E.
Lehman, Vance T.
author_sort Larson, Anthony S.
collection PubMed
description BACKGROUND: This study characterized vessel wall imaging (VWI) features of Moyamoya disease (MMD) in a predominantly adult population at a North American center. METHODS: Consecutive patients with VWI were included. Twelve arterial segments were analyzed for wall thickening, degree and pattern of contrast enhancement, and remodeling. RESULTS: Overall, 286 segments were evaluated in 24 patients (mean age = 36.0 years [range = 1–58]). Of 172 affected segments, 163 (95%) demonstrated negative remodeling. Complete vessel wall obliteration was most frequent in the proximal M1 (17/48, 35%). Affected segments enhanced in 72/172 (42%) (n = 15 for grade II; n = 54 for concentric and n = 18 for eccentric); 20 of 24 (83%) patients had at least one enhancing segment. Both enhancing and non-enhancing segments were present in 19/20 (95%) patients. Vessel wall enhancement was most common in the proximal segments and correlated to the degree of stenosis (p < 0.001), and outer wall diameter (p < 0.001), but not disease duration (p = 0.922) or Suzuki score (p = 0.477). Wall thickening was present in 82/172 (48%) affected segments and was associated with contrast enhancement (p < 0.001), degree of stenosis (p < 0.001), and smaller outer wall diameter (p = 0.004). CONCLUSION: This study presents VWI findings in North American patients with MMD. Negative remodeling was the most common finding. Most patients had both enhancing and non-enhancing abnormal segments. Vessel wall enhancement was most common in proximal segments, variable in pattern or degree and was correlated to the degree of stenosis and smaller outer wall diameter.
format Online
Article
Text
id pubmed-9673330
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96733302022-11-19 Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis Larson, Anthony S. Klaas, James P. Johnson, Matthew P. Benson, John C. Shlapak, Darya Lanzino, Giuseppe Savastano, Luis E. Lehman, Vance T. BMC Med Imaging Research BACKGROUND: This study characterized vessel wall imaging (VWI) features of Moyamoya disease (MMD) in a predominantly adult population at a North American center. METHODS: Consecutive patients with VWI were included. Twelve arterial segments were analyzed for wall thickening, degree and pattern of contrast enhancement, and remodeling. RESULTS: Overall, 286 segments were evaluated in 24 patients (mean age = 36.0 years [range = 1–58]). Of 172 affected segments, 163 (95%) demonstrated negative remodeling. Complete vessel wall obliteration was most frequent in the proximal M1 (17/48, 35%). Affected segments enhanced in 72/172 (42%) (n = 15 for grade II; n = 54 for concentric and n = 18 for eccentric); 20 of 24 (83%) patients had at least one enhancing segment. Both enhancing and non-enhancing segments were present in 19/20 (95%) patients. Vessel wall enhancement was most common in the proximal segments and correlated to the degree of stenosis (p < 0.001), and outer wall diameter (p < 0.001), but not disease duration (p = 0.922) or Suzuki score (p = 0.477). Wall thickening was present in 82/172 (48%) affected segments and was associated with contrast enhancement (p < 0.001), degree of stenosis (p < 0.001), and smaller outer wall diameter (p = 0.004). CONCLUSION: This study presents VWI findings in North American patients with MMD. Negative remodeling was the most common finding. Most patients had both enhancing and non-enhancing abnormal segments. Vessel wall enhancement was most common in proximal segments, variable in pattern or degree and was correlated to the degree of stenosis and smaller outer wall diameter. BioMed Central 2022-11-17 /pmc/articles/PMC9673330/ /pubmed/36397005 http://dx.doi.org/10.1186/s12880-022-00930-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Larson, Anthony S.
Klaas, James P.
Johnson, Matthew P.
Benson, John C.
Shlapak, Darya
Lanzino, Giuseppe
Savastano, Luis E.
Lehman, Vance T.
Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title_full Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title_fullStr Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title_full_unstemmed Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title_short Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
title_sort vessel wall imaging features of moyamoya disease in a north american population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673330/
https://www.ncbi.nlm.nih.gov/pubmed/36397005
http://dx.doi.org/10.1186/s12880-022-00930-2
work_keys_str_mv AT larsonanthonys vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT klaasjamesp vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT johnsonmatthewp vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT bensonjohnc vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT shlapakdarya vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT lanzinogiuseppe vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT savastanoluise vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis
AT lehmanvancet vesselwallimagingfeaturesofmoyamoyadiseaseinanorthamericanpopulationpatternsofnegativeremodellingcontrastenhancementwallthickeningandstenosis